<DOC>
	<DOCNO>NCT02884492</DOCNO>
	<brief_summary>This study do learn tau tangle Alzheimer 's disease . A type PET scan use measure abnormal accumulation protein call tau brain . These think involve Alzheimer 's disease . The investigator also perform brain MRI test measure participant 's memory thinking .</brief_summary>
	<brief_title>Imaging Tau Alzheimer 's Disease Normal Aging</brief_title>
	<detailed_description>This study do determine relationship tau tangle cognitive impairment elderly subject different clinical biomarker profile Alzheimer 's disease ( AD ) . Subjects undergo screen include neuropsychological test brain MRI . This study use special type scan call PET scan take picture brain . During PET scan , special radioactive dye call 18F-THK-5351 injected body . 18F-THK-5351 stick abnormal tangle make protein tau . Subjects option lumbar puncture perform measure CSF concentration biomarkers .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>1 . Age 60 old . 2 . Meet criterion either ) amnestic mild cognitive impairment ( single mixed domain ) mild Alzheimer 's disease , b ) cognitive impairment , base history , exam , neuropsychological testing , consensus diagnosis . MCI mild AD patient must Clinical Dementia Rating scale score 0.5 1 . Unimpaired subject must Clinical Dementia Rating scale score 0 . 3 . Subjects unable provide inform consent must surrogate decision maker . 4 . Written oral fluency English Spanish . 5 . Able participate schedule evaluation complete require test procedure . 6 . In opinion investigator , subject must consider likely comply study protocol high probability complete study . 1 . Past present history certain brain disorder MCI AD . 2 . Certain significant medical condition , make study procedure current study unsafe . Such serious medical condition include uncontrolled epilepsy multiple serious injury . 3 . Contraindication MRI scanning . 4 . Conditions preclude entry scanner ( e.g . morbid obesity , claustrophobia , etc. ) . 5 . History kidney disease presence impair kidney function base laboratory test screen visit . 6 . History liver disease presence impair liver function base laboratory test screen visit . 7 . Participation last year clinical trial disease modify drug AD . 8 . Inability catheter subject 's vein injection radioligand . 9 . Inability blood drawn subject 's vein .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>inflammation</keyword>
	<keyword>age</keyword>
	<keyword>mild cognitive impairment</keyword>
</DOC>